Immunocellular Therapeutics, Ltd.
SEC CIK 822411 · IMUC · last insider filing 2018-06-08
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Yu John S | Director · See Remarks | filed 2012 - 2018 |
| Gengos Andrew | Director · President and CEO | filed 2012 - 2017 |
| Titus Gary | Director · Chairman and Secretary | filed 2013 - 2016 |
| Singhvi Rahul | Director | filed 2012 - 2016 |
| Lapointe Gregg Anthony | Director | filed 2015 - 2016 |
| Schlossberg Mark A | Director | filed 2015 - 2016 |
| Chin Richard | Director | filed 2012 - 2014 |
| Kim Helen Susan | Director | filed 2012 - 2014 |
| Cowell Richard | Director | filed 2012 - 2013 |
| Brandwynne Jacqueline | Director | filed 2012 - 2012 |
| Singh Manish | Director · President & CEO | filed 2012 - 2012 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Fractor David | VP of Finance | filed 2012 - 2016 |
| Gringeri Anthony | Sr. VP, Strategic Resources | filed 2013 - 2016 |
| Swanson Steven J | Senior Vice President, Researc | filed 2015 - 2016 |
| Bender James G. | VP, Product Development & Mfg. | filed 2012 - 2013 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.